Purification of acetyl-p53 using p300 co-infection and the baculovirus expression system

Landon G Piluso1, Gang Wei, Andrew G Li

  • 1Department of Biochemistry, University of California, Riverside CA 92521, USA.

Insights

Researchers developed a novel in vivo method to produce highly pure acetylated p53, a crucial tumor suppressor protein. This technique overcomes challenges in obtaining sufficient quantities of acetyl-p53 for accurate cellular studies.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • DNA damage triggers p53 stabilization, a tumor suppressor that regulates cell cycle arrest and apoptosis.
  • While p53 phosphorylation is well-studied, its acetylation in response to DNA damage also impacts function.
  • Accurate in vitro studies necessitate highly pure acetylated p53, which is difficult to obtain using conventional methods.

Purpose of the Study:

  • To develop an efficient strategy for producing high-purity acetylated p53 in vitro.
  • To overcome the technical challenges and inefficiencies associated with current methods for purifying acetyl-p53.

Main Methods:

  • Co-infection of p53 and p300 baculoviruses in Sf21 insect cell culture.
  • Immunoaffinity recovery of acetylated p53.
  • Depletion of unacetylated p53.

Main Results:

  • Developed an in vivo strategy to rapidly produce microgram quantities of p53 with over 60% acetylation.
  • Achieved >70-75% acetyl-p53 purity after one round of immunoaffinity recovery and depletion.
  • Attained undetectable levels of unacetylated p53 after two rounds of purification.

Conclusions:

  • The developed in vivo method provides a rapid and efficient way to produce highly pure acetylated p53.
  • This approach may be applicable to the preparation of other acetylated proteins, including transcription factors and histones.
  • Facilitates further investigation into the roles of acetylated p53 in cellular processes.

Related Concept Videos